Advanced Emissions Solutions Announces Board Changes
Apr 11, 2018 20:37 pm UTC| Business
HIGHLANDS RANCH, Colo., April 11, 2018 -- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the “Company" or “ADES”) today announced that two of its directors - A. Bradley Gabbard and Derek C. Johnson have chosen not to...
CORRECTION FOR WRONG DATE: Ahold Delhaize shareholders adopt all AGM resolutions
Apr 11, 2018 20:31 pm UTC| Business
This is a correction of the announcement from 18:00 11.04.2018 CEST. Reason for the correction: original announcement used wrong date (year)Zaandam, the Netherlands, April 11, 2018 - Ahold Delhaize today held its Annual...
Apr 11, 2018 20:30 pm UTC| Business
VANCOUVER, Washington, April 11, 2018 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company developing new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that an abstract with...
Home Federal Bancorp, Inc. of Louisiana Announces Declaration of Quarterly Cash Dividend
Apr 11, 2018 20:30 pm UTC| Business
SHREVEPORT, La., April 11, 2018 -- Home Federal Bancorp, Inc. of Louisiana (the “Company”) (NASDAQ:HFBL) the holding company for Home Federal Bank announced today that its Board of Directors at their meeting on April...
Kinsale Capital Group Announces First Quarter Earnings Release Date and Conference Call
Apr 11, 2018 20:30 pm UTC| Business
RICHMOND, Va., April 11, 2018 -- Kinsale Capital Group, Inc. (NASDAQ:KNSL) announced today that it will release financial results for the first quarter of 2018 after the market closes on Thursday, May 3, 2018. The...
Apr 11, 2018 20:22 pm UTC| Business
NEW YORK, April 11, 2018 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Central District of California...
Bellicum Announces Clinical Hold Lifted on U.S. Studies of BPX-501
Apr 11, 2018 20:17 pm UTC| Business
HOUSTON, April 11, 2018 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the...